As of 2024-12-14, the Relative Valuation of Puma Biotechnology Inc (PBYI) is 12.68 USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.92 USD, the upside of Puma Biotechnology Inc based on Relative Valuation is 334.2%.
The range of the Relative Valuation is 8.88 - 21.12 USD.
| Range | Selected | |
| Trailing P/E multiples | 27.9x - 44.6x | 34.8x |
| Forward P/E multiples | 19.6x - 30.6x | 19.6x |
| Fair Price | 8.88 - 21.12 | 12.68 |
| Upside | 204.2% - 623.1% | 334.2% |
| Date | P/E |
| 2024-12-10 | 6.38 |
| 2024-12-09 | 6.17 |
| 2024-12-06 | 6.59 |
| 2024-12-05 | 6.48 |
| 2024-12-04 | 6.67 |
| 2024-12-03 | 6.91 |
| 2024-12-02 | 6.76 |
| 2024-11-29 | 7.16 |
| 2024-11-27 | 6.82 |
| 2024-11-26 | 6.63 |
| 2024-11-25 | 6.38 |
| 2024-11-22 | 6.34 |
| 2024-11-21 | 6.13 |
| 2024-11-20 | 6.00 |
| 2024-11-19 | 5.79 |
| 2024-11-18 | 5.79 |
| 2024-11-15 | 5.11 |
| 2024-11-14 | 6.32 |
| 2024-11-13 | 6.27 |
| 2024-11-12 | 6.78 |
| 2024-11-11 | 6.97 |
| 2024-11-08 | 6.08 |
| 2024-11-07 | 6.40 |
| 2024-11-06 | 6.46 |
| 2024-11-05 | 6.25 |
| 2024-11-04 | 6.23 |
| 2024-11-01 | 6.23 |
| 2024-10-31 | 6.02 |
| 2024-10-30 | 6.00 |
| 2024-10-29 | 5.89 |
| 2024-10-28 | 5.98 |
| 2024-10-25 | 6.23 |
| 2024-10-24 | 5.91 |
| 2024-10-23 | 5.94 |
| 2024-10-22 | 6.00 |
| 2024-10-21 | 5.94 |
| 2024-10-18 | 6.08 |
| 2024-10-17 | 5.98 |
| 2024-10-16 | 6.08 |
| 2024-10-15 | 6.02 |
| 2024-10-14 | 6.02 |
| 2024-10-11 | 6.02 |
| 2024-10-10 | 5.72 |
| 2024-10-09 | 5.60 |
| 2024-10-08 | 5.53 |
| 2024-10-07 | 5.62 |
| 2024-10-04 | 5.60 |
| 2024-10-03 | 5.32 |
| 2024-10-02 | 5.20 |
| 2024-10-01 | 5.49 |